Tolmar Wins Auction for Testosterone Therapy Jatenzo Under Clarus' Bankruptcy Proceedings
Express News | Clarus Therapeutics Announces Completion of Auction for Sale of Jatenzo Selection of Tolmar, as Successful Bidder
Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (
Bankrupt Clarus Says Tolmar Is Winning Bidder for Testosterone Drug -- Market Talk
1651 ET - Clarus Therapeutics Holdings, the maker of testosterone drug Jatenzo, says Tolmar Inc. is the winning bidder for its assets in a bankruptcy-court auction. Clarus, based in Northbrook, Ill.,
No Data